{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:55:18Z","timestamp":1780541718508,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Shandong Provincial Key Research and Development Program","award":["2017GSF18159"],"award-info":[{"award-number":["2017GSF18159"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation, China","doi-asserted-by":"publisher","award":["ZR2017BH029"],"award-info":[{"award-number":["ZR2017BH029"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation, China","doi-asserted-by":"publisher","award":["BS2015YY023"],"award-info":[{"award-number":["BS2015YY023"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Fund","award":["2017JC004"],"award-info":[{"award-number":["2017JC004"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601441"],"award-info":[{"award-number":["81601441"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.antiviral.2018.11.006","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T12:57:49Z","timestamp":1542286669000},"page":"36-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["5\u2032-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice"],"prefix":"10.1016","volume":"161","author":[{"given":"Qiuju","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3093-0279","authenticated-orcid":false,"given":"Zhaohua","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-6676","authenticated-orcid":false,"given":"Cai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5106-1397","authenticated-orcid":false,"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.11.006_bib1","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/AAC.06050-12","article-title":"Antiviral effects of small interfering RNA simultaneously inducing RNA interference and type 1 interferon in coxsackievirus myocarditis","volume":"56","author":"Ahn","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.11.006_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4049\/jimmunol.0901245","article-title":"Immunostimulatory RNA blocks suppression by regulatory T cells","volume":"184","author":"Anz","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib3","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.11.006_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2013.09.050","article-title":"5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells","volume":"721","author":"Chen","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/cmi.2017.139","article-title":"Tumor necrosis factor: the key to hepatitis B viral clearance","volume":"15","author":"Chyuan","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2015.10.013","article-title":"Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy","volume":"64","author":"de Niet","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1440-1746.2004.03529.x","article-title":"Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2)","volume":"20","author":"Duan","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2011.05.001","article-title":"5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice","volume":"141","author":"Ebert","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.11.006_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.11.006_bib10","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1158\/0008-5472.CAN-11-3850","article-title":"Therapeutic efficacy of bifunctional siRNA combining TGF-beta 1 silencing with RIG-I activation in pancreatic cancer","volume":"73","author":"Ellermeier","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2018.11.006_bib11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.bbrc.2015.03.145","article-title":"RIG-I-dependent antiviral immunity is effective against an RNA virus encoding a potent suppressor of RNAi","volume":"460","author":"Fan","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2018.11.006_bib12","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.4049\/jimmunol.1501362","article-title":"Polarization of monocytic myeloid-derived suppressor cells by hepatitis B surface antigen is mediated via ERK\/IL-6\/STAT3 signaling feedback and restrains the activation of T cells in chronic hepatitis B virus infection","volume":"195","author":"Fang","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.24505","article-title":"Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner","volume":"54","author":"Han","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.11.006_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00281-017-0641-1","article-title":"Tolerance and immunity to pathogens in early life: insights from HBV infection","volume":"39","author":"Hong","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib15","doi-asserted-by":"crossref","first-page":"17862","DOI":"10.1073\/pnas.0608578103","article-title":"An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection","volume":"103","author":"Huang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.11.006_bib16","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s13238-010-0141-8","article-title":"Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein","volume":"1","author":"Jiang","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.antiviral.2018.11.006_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004210","article-title":"Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver","volume":"10","author":"Jo","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.11.006_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","volume":"479\u2013480","author":"Kell","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.11.006_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.26339","article-title":"Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance","volume":"58","author":"Lan","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.11.006_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.leukres.2017.03.010","article-title":"5'-Triphosphate siRNA targeting MDR1 reverses multi-drug resistance and activates RIG-I-induced immune-stimulatory and apoptotic effects against human myeloid leukaemia cells","volume":"58","author":"Li","year":"2017","journal-title":"Leuk. Res."},{"key":"10.1016\/j.antiviral.2018.11.006_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14218\/JCTH.2015.00026","article-title":"The role of immune cells in chronic HBV infection","volume":"3","author":"Li","year":"2015","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib22","doi-asserted-by":"crossref","first-page":"10359","DOI":"10.1128\/JVI.00665-12","article-title":"5'-Triphosphate-short interfering RNA: potent inhibition of influenza A virus infection by gene silencing and RIG-I activation","volume":"86","author":"Lin","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1586\/17474124.2016.1145547","article-title":"Hepatitis B: treatment choice and monitoring for response and resistance","volume":"10","author":"Liu","year":"2016","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib24","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/ijc.28416","article-title":"Multifunctional antitumor molecule 5'-triphosphate siRNA combining glutaminase silencing and RIG-I activation","volume":"134","author":"Meng","year":"2014","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.antiviral.2018.11.006_bib25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jhep.2014.12.026","article-title":"Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B","volume":"62","author":"Menne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib26","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nm.1887","article-title":"5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma","volume":"14","author":"Poeck","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2018.11.006_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.immuni.2009.05.008","article-title":"Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus","volume":"31","author":"Schlee","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2018.11.006_bib28","doi-asserted-by":"crossref","first-page":"12067","DOI":"10.1073\/pnas.0900971106","article-title":"5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I","volume":"106","author":"Schmidt","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.11.006_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2014.00258","article-title":"The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection","volume":"5","author":"Schuch","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib31","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021428","article-title":"Immune response in hepatitis B virus infection","volume":"5","author":"Tan","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2018.11.006_bib32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12072-013-9504-6","article-title":"Basis of HBV persistence and new treatment options","volume":"8","author":"Thursz","year":"2014","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.antiviral.2018.11.006_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2017.09.017","article-title":"Interplay between dengue virus and Toll-like receptors, RIG-I\/MDA5 and microRNAs: implications for pathogenesis","volume":"147","author":"Urcuqui-Inchima","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.11.006_bib34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/CJI.0b013e318294183b","article-title":"5'-triphosphate-siRNA against survivin gene induces interferon production and inhibits proliferation of lung cancer cells in vitro","volume":"36","author":"Wang","year":"2013","journal-title":"J. Immunother."},{"key":"10.1016\/j.antiviral.2018.11.006_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/cmi.2010.36","article-title":"Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex","volume":"7","author":"Wang","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bjid.2015.05.006","article-title":"Natural killer cells in hepatitis B virus infection","volume":"19","author":"Wu","year":"2015","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.11.006_bib37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/cmi.2016.24","article-title":"Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction","volume":"14","author":"Yang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2018.11.006_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-065X.2008.00727.x","article-title":"RNA recognition and signal transduction by RIG-I-like receptors","volume":"227","author":"Yoneyama","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2018.11.006_bib39","doi-asserted-by":"crossref","first-page":"29664","DOI":"10.18632\/oncotarget.4869","article-title":"Anti-angiogenic efficacy of 5'-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs","volume":"6","author":"Yuan","year":"2015","journal-title":"Oncotarget"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218300275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218300275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T09:43:22Z","timestamp":1565257402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218300275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":39,"alternative-id":["S0166354218300275"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.11.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5\u2032-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}